Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01716806
Title A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seattle Genetics, Inc.

Hodgkin's lymphoma


Brentuximab vedotin + Nivolumab

Bendamustine + Brentuximab vedotin

Brentuximab vedotin + Dacarbazine

Brentuximab vedotin

Age Groups: senior | adult
Covered Countries USA | CAN

No variant requirements are available.